Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 22.02
-1.61 (-6.81%)
Oct 30, 2026, 3:04 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 18.72 billion as of October 30, 2026. It is the 5,245th most valuable company in the world and the 808th biggest in China. Its market cap has increased by 24.17% in one year.
Market Cap
18.72B
Enterprise Value
17.73B
Revenue
2.10B
Global Rank
Country Rank
#808 China
PE Ratio
91.66
ChartMarket Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 18.72B, an increase of 159.39%. That is a compound annual growth rate of 5.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 18.72B | 16.02% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 22.07B |
| Livzon Pharmaceutical Group | 21.95B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.64B |
| Tasly Pharmaceutical Group | 20.39B |
| Hybio Pharmaceutical | 20.14B |
| Jilin Aodong Pharmaceutical Group | 19.43B |
| Walvax Biotechnology | 18.94B |
| Joincare Pharmaceutical Group Industry | 18.13B |